Cardiovascular

The Cardiovascular Clinical Academic Group (CV CAG) aims to deliver improved cardiovascular health outcomes through high impact multidisciplinary and collaborative research involving the expertise of clinicians, researchers and consumers.

Join the CAG

About the group

The CV CAG emphasises activities in capacity and capability building in research translation with a focus on Early-Mid Career Researchers (EMCRs) and clinician researchers.

The CV CAG is the research translation focus of the broader Cardiovascular Initiative (CVI) network, a strategic partnership between Sydney Health Partners, the University of Sydney’s Charles Perkins Centre and the Faculty of Medicine and Health.

The CVI has six multidisciplinary pipelines each co-led by a fundamental researcher and clinician, to help achieve its vision:

Implementation and Policy
Precision Medicine
Drug Discovery
Bioengineering
Big Data
Clinical Trials

Objectives

The CV CAG is entering its second round of funding, 2024-2026. Building on activities from Round 1, the new strategy focusses on:

Research in the development and evaluation of new cardiovascular services and innovative approaches in cardiovascular clinical care with priority research questions addressing effectiveness and implementation
Cardiovascular projects with expertise to enable economic evaluation of new cardiovascular models of care and innovative clinical approaches
Innovative cardiovascular services and clinical innovation research projects to conduct research that informs future scale up, through leveraging SHP partners, including consumers networks

Get involved

Interested in finding out more about the Cardiovascular CAG or joining?

Join the CAG Get in touch

Projects and Initiatives

Development of virtual eMR derived clinical quality registries – Lead: Professor David Brieger
Established Implementation Pilot Grants: to encourage a Clinician to co-lead a diverse team of health professionals, clinicians, and researchers to develop, pilot or evaluate new cardiovascular health services and innovative approaches in cardiovascular clinical care.
Establishment of Cardiovascular Genetics Working Group in collaboration with the Genomics and Precision Medicine CAG to identify current CV Genetics Services in Australia including patient journeys and develop a new model of clinical care
Creation of membership survey and database
Finalised ToR for the CVCAG Leadership Team and EOI to recruit new members

Milestones

Greater connectivity with the health system, across LHDs and with NSW Health, to align activities and research priorities.
Increased membership of CAG with formal survey and database created which captures member’s affiliations, areas of expertise and research interests.
Connectivity with whole-of-pipeline CVI- fundamental discoveries relevant to clinical problems, with pathway for translation (including ASHRA and CAD Frontiers).
Active involvement of EMCRs; in the leadership team and event planning and supported as CIs on seed grants.
Launched and awarded 3 x Implementation Pilot Grants co-led by EMCRs to develop and or test an innovative MoC.
Delivered CV Genetics Workshop in collaboration with the Genomics and Precision Medicine CAG. This has generated manuscripts and a scope of work to investigate current practices and services, to map the patient’s journey and to understand the needs of consumers and stakeholders.
New Leadership Team established with representation across LHDs, discipline areas and career stages.

What’s next

Further Cross- CAG collaboration to effectively target priority areas identified, including establishment of working groups and delivery of workshops to target:

Structural Heart Disease
Obesity and Heart Disease – collaborating with the Diabetes and Obesity CAG

Join the Cardiovascular CAG

Be part of a collaborative network driving research that makes a real difference to cardiovascular health.

We welcome clinicians, researchers, policy makers, and consumers with an interest in improving cardiovascular health outcomes. Whether you’re early in your career or an established leader, your voice adds value.

Join the CAG Get In Touch

Why join

Collaborate on high-impact, translational research
Access mentoring, training and funding opportunities
Influence research priorities and co-design meaningful studies
Contribute to better outcomes through evidence-informed policy and practice

News and Stories of Impact

Collaborative Spirit on Display at NSW Research Translation Centres’ Cardiovascular Symposium

The event brought together leading cardiovascular disease clinicians and researchers from Clinical Academic Groups (CAGs) at Sydney Health Partners and Maridulu Budyari Gumal…

Sydney Health Partners Expands Clinical Academic Group Program

The new CAGs have been chosen through a rigorous assessment process and final recommendations ratified by the Board of Sydney Health Partners. The…

Leadership Team

The Leadership Team was reviewed in 2025 as several members no longer worked at the University or within the Sydney LHDs or had commitments which prevented them from continuing as a member of the Leadership Team.

Thank you to Profs David Brieger, David Celermajer, Kaz Negishi, Julie Redfern and Chris Semsarian for their support of the CV CAG and participation in the inaugural CV CAG Leadership Team.

The team continues to be led by Profs Clara Chow and Gemma Figtree as co-chairs and includes representation across the LHDs and CVD disciplines, including: